Termination of Registration of a Class of Security Under Section 12(g) (15-12g)
December 22 2017 - 4:53PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 15
CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER
SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION
OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934.
Commission
File Number
0-50481
Aeolus Pharmaceuticals, Inc.
(Exact name of registrant as specified in its charter)
26361 Crown Valley Parkway, Suite 150, Mission Viejo, CA
92691
(Address, including zip code, and telephone number, including area
code,
of registrant’s principal executive offices)
Common Stock
(Title of each class of securities covered by this
Form)
N/A
(Titles of all other classes of securities for which a duty to file
reports
under section 13(a) or 15(d) remains)
Please
place an X in the box(es) to designate the appropriate rule
provision(s) relied upon to terminate or suspend the duty to file
reports:
Rule 12g-4(a)(1)
|
☒
|
|
|
|
|
Rule 12g-4(a)(2)
|
☐
|
|
|
|
|
Rule 12h-3(b)(1)(i)
|
☒
|
|
|
|
|
Rule 12h-3(b)(1)(ii)
|
☐
|
|
|
|
|
Rule 15d-6
|
☐
|
|
|
|
|
Rule
15d-22(b)
|
☐
|
|
Approximate
number of holders of record as of the certification or notice date:
120
Pursuant
to the requirements of the Securities Exchange Act of 1934
[Name of registrant as specified
in charter]
has caused this certification/notice to be
signed on its behalf by the undersigned duly authorized
person.
Date:
December 22, 2017
|
By:
|
/s/ David C.
Cavalier
|
|
|
David C. Cavalier
|
Aeolus Pharmaceuticals (CE) (USOTC:AOLS)
Historical Stock Chart
From Jul 2024 to Aug 2024
Aeolus Pharmaceuticals (CE) (USOTC:AOLS)
Historical Stock Chart
From Aug 2023 to Aug 2024